SurinabantAlternative Names: SR147778
Latest Information Update: 04 Nov 2008
At a glance
- Originator sanofi-aventis
- Class Amides; Drug withdrawal therapies; Obesity therapies; Piperidines; Pyrazoles; Smoking cessation therapies
- Mechanism of Action Cannabinoid receptor CB1 antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Alcoholism; Obesity; Psychotic disorders; Smoking withdrawal